Analytic framework illustrating exposure to preventive measures that reduce the risk of transmission between HIV-serodiscordant sex partners. Analytic.

Slides:



Advertisements
Similar presentations
Factors Associated with Potential Exposure to and Transmission of HIV in a Probability Sample of Men Who Have Sex with Men Devon D. Brewer Matthew R. Golden.
Advertisements

Women and ARV-based Prevention: Challenges and Opportunities Tim Mastro, MD, DTM&H AIDS 2014 Melbourne, Australia 24 July 2014.
STDs Valerie Robinson D.O.. Prevention Abstinence Risk reduction Vaccines Male or female condoms Cervical diaphragm might protect against cervical GC,
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
Genital Herpes Prevention and Clinical Services: What Should Health Departments Do Now? H. Hunter Handsfield, M.D. University of Washington Public Health.
Monica Gandhi MD, MPH Associate Professor and Women’s HIV Clinic provider, HIV/AIDS Division San Francisco General Hospital/ UCSF Safe Poz Love, U.S. Positive.
1 MMWR (60), Of all with HIV infection, ~850,000 individuals do not have suppressed HIV RNA (72%) 100 % 75% 50% 25% 80 % 77 % 66 % 77 % 89 % Gaps.
Treatment as prevention (TASP) for HIV and HCV: The evidence and modelling Peter Vickerman.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
TasP is not enough Stipulated that TasP is effective in reducing infectiousness of the treated person – But much more is required. TasP requires effective.
Late HIV Diagnoses, Georgia,
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Myths and Misconceptions
Undetectable = Uninfectious ? Treatment as Prevention.
HIV/AIDS Presented by Kunphen center for substance dependence and HIV/AIDS.
HIV & AIDS. HIV INFECTION HIV-The most serious incurable STI HIV-Human Immunodeficiency Virus.
RESULTS METHODS Pre-exposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child P. Vernazza 1 I. Brenner 1, I. Graf.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Sophia Osawe (BSc, AIMLS) Institute of Human Virology, Nigeria Nigerian Canadian Collaboration on AIDS Vaccines (NICCAV) Study Coordinator Discordant Couples.
GAP Report 2014 People left behind: People aged 50 years and older Link with the pdf, People aged 50 years and older.
Implementation of HIV Treatment as Prevention in China Yan Zhao MD National Center for AIDS/STD Control & Prevention Chinese Center for Disease Control.
Immigration Removal Centres and HIV Clinical Care Jane Anderson Homerton University Hospital NHS Foundation Trust.
HIV Care Continuum New Diagnoses, 2011, Fulton County, Georgia.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000.
IHBSS 2009 Initial results (national). Knowledge on HIV.
Gendered sexual risk patterns and polygamy among HIV sero-discordant couples in Uganda Sarah Khanakwa, 1 Moses Ngolobe, 2,3 David Moore, 4 Robert Mwesigwa,
High-impact interventions. Number of people living with HIV who were not receiving antiretroviral therapy, 2014 and 2015 Source: UNAIDS estimates, 2014.
Monodisciplinary, Multidisciplinary, Interdisciplinary, and Transdisciplinary Approaches to Reproductive Health Research II William A. Fisher, Ph.D Department.
The HIV Care Continuum: A Tool for Driving Systematic Change to Support Better Engagement in Care Jeffrey S. Crowley Distinguished Scholar/ Program Director.
Risk of Sexual Transmission under HAART Background information on Swiss statement Pietro Vernazza President EKAF- Swiss Federal Commission on AIDS.
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) HIV Prevention Training Package Session 2: Combination.
Grinsztejn B, et al, Lancet Infect Dis, March 4 th 2014 PRIMARY COMBINED M&M OUTCOME FIRST AIDS DEFINING EVENT FIRST TB EVENT DEATH.
Dual Protection = prevent pregnancy + avoid STI/HIV.
Washington D.C., USA, July 2012www.aids2012.org Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples: a systematic.
HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent
New Prevention Technologies Workshop Module 2: NPTs in context
Antiretrovirals for HIV Prevention: Progress and Challenges Kenneth H. Mayer, M.D. Brown/Miriam/Fenway.
Figure 2: Trends in currently prescribed antiretroviral therapy % prescribed HAART increased from 74% to 83% Trends in ART use, HIV viral load, and CD4.
New Developments in HIV Kerri Howley Coordinator – The Green Room
HIV Prevention: A Winnable Battle Centers for Disease Control and Prevention.
BRADFORD BRIGGS & NIKE JACKSON. BRADFORD BRIGGS Prevention Toolbox.
Dr. Doug Masini.  ABC approach: Abstain, Be Faithful, and correct and consistent use of Condoms  Prevention of mother to child transmission (PMTCT)
The Epidemiology of STIs in the HIV and AIDS Era
Module 4 (e) Pregnancy and Breast Feeding
COMBINATION PREVENTION
Continuum of HIV Care, Treatment, and Prevention
Status Neutral: The New Normal for HIV
PrEP as an HIV Prevention Tool in Queer Communities of Color: Barriers and Opportunities BACKGROUND Joanne Stekler, MD MPH.
HIV Care Continuum in Manhattan
Provider Initiated HIV Counseling and Testing
PrEP: A Case-by-Case Approach
HIV and the ART of Prevention
HIV and AIDS.
Stacey A. Rizza, MD, Robin J. MacGowan, MPH, David W
Global Optimization of the Response to HIV
100 Partners PrEP[5] Efficacy 75% Adherence 81% 80
Distribution of HIV incidence by mode of exposure in Peru:
Volume 3, Issue 7, Pages e289-e296 (July 2016)
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
HIV.
U=U Guidance for Implementation in Clinical Settings
Hypothetical pathway for the association between exposure to household disinfectant and body mass index (BMI) z score at age 3 years. a, b1, ADE, ACME.
Overview of HIV Prevention Cascade Discussions. Geoff Garnett
Effect of methylprednisolone versus placebo on the risk of acute kidney injury in a subsample of patients with serial postoperative serum creatinine assessments.
Managing Hepatitis C in Vermont
Fig. 1: Ampule of vitamin K
Undetectable = Untransmittable
Relative risk by median risk exposure for 40-year-old men.
Presentation transcript:

Analytic framework illustrating exposure to preventive measures that reduce the risk of transmission between HIV-serodiscordant sex partners. Analytic framework illustrating exposure to preventive measures that reduce the risk of transmission between HIV-serodiscordant sex partners. The numbers in the corresponding pathways illustrate the risk of HIV transmission from the HIV-positive partner to the HIV-negative partner during sex for Q1 to Q5. Note: Q1 = to determine risk when a sex partner who is HIV-positive is taking antiretroviral therapy (with varying levels of viral load); Q2 = to determine risk when a sex partner who is HIV-positive is taking antiretroviral therapy and has a suppressed viral load; Q3 = to determine risk when a sex partner who is HIV-positive is taking antiretroviral therapy and either partner uses condoms (or other barrier methods); Q4 = to determine risk when a sex partner who is HIV-positive is taking antiretroviral therapy and has a suppressed viral load, and either partner uses condoms (or other barrier methods); Q5 = to determine risk when either partner uses condoms (or barrier methods) alone. Jennifer LeMessurier et al. CMAJ 2018;190:E1350-E1360 ©2018 by Canadian Medical Association